BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 23013419)

  • 21. Progressive outer retinal necrosis in a patient with cutaneous non-Hodgkin's T cell lymphoma (Sézary syndrome).
    Njoo FL; Rothova A; Van Der Lelij A
    Br J Ophthalmol; 1998 Oct; 82(10):1218-9. PubMed ID: 9924317
    [No Abstract]   [Full Text] [Related]  

  • 22. Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T cells in Sézary syndrome.
    Willerslev-Olsen A; Buus TB; Nastasi C; Blümel E; Gluud M; Bonefeld CM; Geisler C; Lindahl LM; Vermeer M; Wasik MA; Iversen L; Becker JC; Andersen MH; Gjerdrum LMR; Litvinov IV; Litman T; Krejsgaard T; Woetmann A; Ødum N
    Blood Cancer J; 2020 May; 10(5):57. PubMed ID: 32409671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The immunopathogenesis of cutaneous T-cell lymphoma. Abnormal cytokine production by Sézary T cells.
    Rook AH; Vowels BR; Jaworsky C; Singh A; Lessin SR
    Arch Dermatol; 1993 Apr; 129(4):486-9. PubMed ID: 8466223
    [No Abstract]   [Full Text] [Related]  

  • 24. A restricted clonal T-cell receptor αβ repertoire in Sézary syndrome is indicative of superantigenic stimulation.
    van der Fits L; Sandberg Y; Darzentas N; Zoutman WH; Tielemans D; Wolvers-Tettero IL; Vermeer MH; Langerak AW
    Br J Dermatol; 2011 Jul; 165(1):78-84. PubMed ID: 21410672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The diagnosis of Sézary syndrome on peripheral blood by flow cytometry requires the use of multiple markers.
    Klemke CD; Brade J; Weckesser S; Sachse MM; Booken N; Neumaier M; Goerdt S; Nebe TC
    Br J Dermatol; 2008 Sep; 159(4):871-80. PubMed ID: 18652582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Heterologous antistaphylococcal gamma-globulin in the treatment of staphylococcal sepsis].
    Shubik IuG; Nemchenko VI
    Vestn Khir Im I I Grek; 1979 Apr; 122(4):46-50. PubMed ID: 87058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neonatal purpura fulminans due to methicillin resistant Staphylococcus aureus.
    Verma P; Pandhi D; Yadav P; Dhawan AK
    Pediatr Dermatol; 2013; 30(2):266-7. PubMed ID: 22276732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sézary syndrome involving the intestinal tract.
    Kokubu H; Nishikawa J; Kato T; Imaeda H; Kito K; Andoh A; Namura T; Moritani S; Tanaka T; Fujimoto N
    Clin Exp Dermatol; 2020 Jun; 45(4):466-469. PubMed ID: 31646657
    [No Abstract]   [Full Text] [Related]  

  • 29. Rapid onset of CD8+ aggressive T-cell lymphoma during bexarotene therapy in a patient with Sézary syndrome.
    Kreuter A; Altmeyer P
    J Am Acad Dermatol; 2005 Dec; 53(6):1093-5. PubMed ID: 16310082
    [No Abstract]   [Full Text] [Related]  

  • 30. IL-12 reverses cytokine and immune abnormalities in Sezary syndrome.
    Rook AH; Kubin M; Cassin M; Vonderheid EC; Vowels BR; Wolfe JT; Wolf SF; Singh A; Trinchieri G; Lessin SR
    J Immunol; 1995 Feb; 154(3):1491-8. PubMed ID: 7822812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No evidence for HTLV-I infection in 24 cases of French and Portuguese mycosis fungoïdes and Sezary syndrome (as seen in France).
    Capésius C; Saal F; Maero E; Bazarbachi A; Lasneret J; Laroche L; Gessain A; Hojman F; Périés J
    Leukemia; 1991 May; 5(5):416-9. PubMed ID: 2033961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of teicoplanin's therapeutic efficacy in immunocompromised patients with staphylococcal sepsis.
    Orani A; Fossati M; Castelli N; Sala A
    J Chemother; 1989 Jul; 1(4 Suppl):716-9. PubMed ID: 16312605
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of IL-10 antisense gene therapy in severely burned mice intradermally infected with MRSA.
    Asai A; Kogiso M; Kobayashi M; Herndon DN; Suzuki F
    Immunobiology; 2012 Jul; 217(7):711-8. PubMed ID: 22209112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus.
    De Gascun C; Rajan L; O'Neill E; Smyth EG
    J Antimicrob Chemother; 2006 Jan; 57(1):150-1. PubMed ID: 16244085
    [No Abstract]   [Full Text] [Related]  

  • 35. Atopic dermatitis-like pre-Sézary syndrome: role of immunosuppression.
    Sokołowska-Wojdyło M; Barańska-Rybak W; Cegielska A; Trzeciak M; Lugowska-Umer H; Gniadecki R
    Acta Derm Venereol; 2011 Sep; 91(5):574-7. PubMed ID: 21681350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. More about the T-cell receptor V beta repertoire usage in mycosis fungoides/Sézary syndrome.
    Bachelez H; Gorochov G
    Br J Dermatol; 1995 Jun; 132(6):1017-8. PubMed ID: 7662555
    [No Abstract]   [Full Text] [Related]  

  • 37. Staphylococcus aureus and Sézary syndrome.
    Merlio JP
    Blood; 2024 Apr; 143(15):1436-1438. PubMed ID: 38602696
    [No Abstract]   [Full Text] [Related]  

  • 38. [Bacterial pericarditis in a patient with Sezary syndrome].
    Hefczyc JZ; Szyguła BE; Wertelecka IC
    Wiad Lek; 2000; 53(9-10):570-3. PubMed ID: 11148927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tendon destruction induced by Panton-Valentine leukocidin-positive Staphylococcus aureus in a patient with Sézary syndrome.
    Yamasaki O; Morizane S; Akiyama H; Iwatsuki K; Kaneko J; Kamio Y
    Br J Dermatol; 2005 Mar; 152(3):586-7. PubMed ID: 15787844
    [No Abstract]   [Full Text] [Related]  

  • 40. From single-cell signature to prognostic factors: the case of Sézary syndrome.
    Scala E; Narducci MG; Russo G
    Expert Rev Clin Immunol; 2012 Nov; 8(8):699-701. PubMed ID: 23167680
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.